Related Experiment Video
Updated: Oct 6, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Evolution in Sinonasal Mucosal Melanoma Management
Tony Richa1, Alice Lee1, Marc A Cohen1
1Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Abstract:
Sinonasal mucosal melanoma is a rare and aggressive cancer with poor prognosis. Surgical resection with clear margins, when possible, remains the treatment of choice. Radiation therapy is generally used in the adjuvant setting with improved rates of local control following complete resection. Traditional chemotherapeutic agents do not improve the rates of locoregional control or survival. Immunotherapy has been used with some responders but with overall relatively poor outcomes. These outcomes highlight the need for new agents and more prospective trials in this space. We provide a unique case report of a patient with an advanced sinonasal mucosal melanoma and an overview of the recent literature pertaining to the management of this disease.

